Stockreport

Motif Bio to present at upcoming investor and scientific conferences

MOTIF BIO PLC ADRS  (MTFB) 
US:NASDAQ Investor Relations: ir.motifbio.com
PDF NEW YORK, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), the clinical stage biopharmaceutical company specialising in developing novel antib [Read more]